| Christy Evers, CNM | |
|
16180 W 135th St, Olathe, KS 66062-1517 | |
| (913) 441-4544 | |
| (913) 422-8462 |
| Full Name | Christy Evers |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 16180 W 135th St, Olathe, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164083713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 2019021636 (Missouri) | Primary |
| Entity Name | Western Missouri Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033106166 PECOS PAC ID: 2062493653 Enrollment ID: O20040528000630 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
› Verified 6 days ago
| Entity Name | Western Missouri Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083601330 PECOS PAC ID: 7416931506 Enrollment ID: O20040616000777 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
› Verified 6 days ago
| Entity Name | Western Missouri Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215388293 PECOS PAC ID: 5092852111 Enrollment ID: O20091022000298 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
› Verified 6 days ago
| Entity Name | Western Missouri Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194275362 PECOS PAC ID: 4183904865 Enrollment ID: O20170512001582 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christy Evers, CNM 16180 W 135th St, Olathe, KS 66062-1517 Ph: (913) 441-4544 | Christy Evers, CNM 16180 W 135th St, Olathe, KS 66062-1517 Ph: (913) 441-4544 |
News Archive
Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced the availability of the QuikClot® Interventional™ hemostatic bandage, on display at booth #1338 at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Speaking at the annual European conference of rheumatology, EULAR 2005, in Vienna, Austria, today (Friday 10 June 2005), Dr. Gurkirpal Singh, from Stanford University, USA, said:
A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
› Verified 6 days ago
Ms. Justine Noelle Flory, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 11875 S Sunset Dr, Olathe, KS 66061 Phone: 913-826-1200 Fax: 913-826-1300 |